Download Medical Notes on Indian API (Active Pharmaceutical Ingredient) Industry

Indian API (Active Pharmaceutical Ingredient) Industry - Reaching The Full Potential Medical Notes

About This Presentation

Description:The pharma industry in India is the world’s third largest if we talk about volume, and is thirteenth largest in terms of value. The pharmaceutical industry in India generates over USD11 billion of trade surplus every year. The industry is among the top 5 sectors contributing to the curtailing of India’s trade deficit. This report by CII in partnership with KPMG tries to encompass the present state of the Indian bulk drug industry, identifies challenges threatening the industry, compares Indian pharma industry with Chinese pharma industry and proposes recommendations to help India establish self-sufficiency in APIs. With an intent to help India establish self-sufficiency and export prowess in the API segment, the recommendations proposed in this report have been constructed around – • Providing ease of doing business • Incentives and subsidies • Infrastructure development and innova

Tags:Indian API, pharma industry, Indian pharma industry, CII, KPMG, Chinese pharma industry, bulk drug industry

Published on: Jun 30, 2020 | Views : 1735 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

The financialisation of Big Pharma

Evaluate Vantage 2020 Preview – A Report on Pharmaceutical Industry

Drug Development with Dutch Public Funding

Pharmacoeconomics

Indian API (Active Pharmaceutical Ingredient) Industry - Reaching The Full Potential

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2019

The Impact of the COVID-19 Pandemic on Global Pharmaceutical Growth

Coronavirus COVID-19 response for Pharma companies

ANTIBIOTICOS

The financialisation of Big Pharma

HEALTH A TO Z